Mitsubishi UFJ Capital is the venture capital arm of the Mitsubishi UFJ Financial Group, founded in 1974. Mitsubishi UFJ Capital uses the networks and resources of the MUFG Group to assist venture startups in growing their business. Based in Tokyo, Japan, the firm invests in sectors such as infrastructure technology, electronics, biotechnology and healthcare.
Mitsubishi UFJ Capital has raised a total of ¥20B across 2 funds, their latest being Mitsubishi UFJ Life Science I. This fund was announced on Feb 20, 2017 and raised a total of ¥10B.
Xiaomi is an electronics company that manufactures and distributes mobile phones and other electronics.
Astroscale is a company that was created to find solutions for orbital debris
bitflyer Inc. is a company that is seen as the largest bitcoin exchange in the world by volume.
Alpaca is an AI and Fintech company in Asia.
Artificial Intelligence company
AI inside Inc. is a Tokyo-based firm engaged in artificial intelligence (AI) solutions.
Fronteo is a technology company that focuses on eDiscovery market and litigation consulting.
Kyoto Robotics Corporation develops and manufactures AI and machine vision-powered robot solutions for the manufacturing and logistics industries.
Quantum Biosystems is a company that provides a sequencing system which assembles genetic data with wide applicability through the use of DNA and RNA sequencing.
Spectronix is a company founded in 2004 by George Okada.
CureApp is a company that is recreating treatment with software.
APB Co., Ltd. is a Tokyo, Japan-based company founded by Hideaki Horie.
Cyfuse Biomedical K.K. is a tissue-engineering technology developing company.
Modalis Therapeutics Corporation is a Cambridge, Massachusetts-based company founded by Haru MORITA.
PointGrab is a company that provides smart sensing solution for smart buildings.
Nanophoton Corporation is a company founded by Satoshi Kawata.
Hibot Corporation is a robotics company using 3D technology.
StemRIM is a company in Osaka, Japan.
CellGenTech, Inc is a company that finds opportunities for alliances to promote the development of gene and cell therapy
Symphony Communication Services provides a cloud-based communications platform.